These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16415598)

  • 1. Sex differences in methamphetamine-evoked striatal dopamine output are abolished following gonadectomy: comparisons with potassium-evoked output and responses in prepubertal mice.
    Dluzen DE; Salvaterra TJ
    Neuroendocrinology; 2005; 82(2):78-86. PubMed ID: 16415598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in methamphetamine-evoked striatal dopamine of mice are reversed by nomifensine.
    Kunnathur V; Shemisa K; Liu B; Salvaterra TJ; Dluzen DE
    Neurotoxicol Teratol; 2006; 28(5):557-62. PubMed ID: 16978834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal dopamine output is compromised within +/- BDNF mice.
    Dluzen DE; Anderson LI; McDermott JL; Kucera J; Walro JM
    Synapse; 2002 Feb; 43(2):112-7. PubMed ID: 11754489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in reserpine-induced striatal dopamine output and content between female and male mice: implications for sex differences in vesicular monoamine transporter 2 function.
    Dluzen DE; Bhatt S; McDermott JL
    Neuroscience; 2008 Jul; 154(4):1488-96. PubMed ID: 18515015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen increases methamphetamine-evoked dopamine output from superfused striatal tissue fragments of male mice.
    Willett MC; Dluzen DE
    Brain Res; 2004 Dec; 1029(2):186-94. PubMed ID: 15542073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone enhances dopamine depletion by methamphetamine in male, but not female, mice.
    Lewis C; Dluzen DE
    Neurosci Lett; 2008 Dec; 448(1):130-3. PubMed ID: 18852023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen, but not testosterone, attenuates methamphetamine-evoked dopamine output from superfused striatal tissue of female and male mice.
    Myers RE; Anderson LI; Dluzen DE
    Neuropharmacology; 2003 Apr; 44(5):624-32. PubMed ID: 12668048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomifensine alters sex differences in striatal dopaminergic function.
    Poth LS; O'Connell BP; McDermott JL; Dluzen DE
    Synapse; 2012 Aug; 66(8):686-93. PubMed ID: 22389194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging and sex differences in striatal dopaminergic function.
    McDermott JL; Dluzen DE
    Neuroscience; 2007 Oct; 149(2):401-8. PubMed ID: 17900817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in K+-evoked striatal dopamine output from superfused striatal tissue fragments of reserpine-treated CD-1 mice.
    Ji J; McDermott JL; Dluzen DE
    J Neuroendocrinol; 2007 Sep; 19(9):725-31. PubMed ID: 17680888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of neonatal and prepubertal hormonal manipulations upon estrogen neuroprotection of the nigrostriatal dopaminergic system within female and male mice.
    Anderson LI; Leipheimer RE; Dluzen DE
    Neuroscience; 2005; 130(2):369-82. PubMed ID: 15664693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships among gender, age, time, and temperature in methamphetamine-induced striatal dopaminergic neurotoxicity.
    Dluzen DE; McDermott JL; Darvesh AS
    Neuroscience; 2010 Jun; 167(4):985-93. PubMed ID: 20211701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in dopamine- and vesicular monoamine-transporter functions.
    Dluzen DE; McDermott JL
    Ann N Y Acad Sci; 2008 Oct; 1139():140-50. PubMed ID: 18991858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system.
    Liu B; Dluzen DE
    Synapse; 2006 Oct; 60(5):354-61. PubMed ID: 16838362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response effects of estrogen and tamoxifen upon methamphetamine-induced behavioral responses and neurotoxicity of the nigrostriatal dopaminergic system in female mice.
    Mickley KR; Dluzen DE
    Neuroendocrinology; 2004; 79(6):305-16. PubMed ID: 15256808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental and genetic influences upon gender differences in methamphetamine-induced nigrostriatal dopaminergic neurotoxicity.
    Dluzen DE; McDermott JL
    Ann N Y Acad Sci; 2004 Oct; 1025():205-20. PubMed ID: 15542719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system of ovariectomized mice.
    Liu B; Dluzen DE
    Neuroendocrinology; 2006; 83(5-6):295-302. PubMed ID: 16926530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol.
    D'Astous M; Gajjar TM; Dluzen DE; Di Paolo T
    Neuroendocrinology; 2004; 79(6):296-304. PubMed ID: 15249736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine transporter function differences between male and female CD-1 mice.
    Bhatt SD; Dluzen DE
    Brain Res; 2005 Feb; 1035(2):188-95. PubMed ID: 15722058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen, anti-estrogen, and gender: differences in methamphetamine neurotoxicity.
    Dluzen DE; McDermott JL
    Ann N Y Acad Sci; 2002 Jun; 965():136-56. PubMed ID: 12105091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.